Bausch Health Companies Inc.
BHC | NYSE
$5.65
+$0.01 (+0.18%)
Sep 22, 2026, 9:37 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 10.45B | 9.63B | 8.76B | 8.12B | 8.43B | 8.03B |
Cost of Revenue | 4.08B | 2.78B | 2.56B | 2.36B | 2.39B | 2.25B |
Gross Profit | 6.36B | 6.84B | 6.2B | 5.76B | 6.04B | 5.78B |
Operating Income | 2.22B | 1.55B | 963M | 454M | 450M | 676M |
Interest Income | 48.84M | 33M | 26M | 14M | 7M | 13M |
Pretax Income | 373.42M | 167M | -390M | -129M | -1.02B | -934M |
Net Income | 159.75M | -46M | -592M | -225M | -948M | -559M |
Selling & General & Admin | 3.5B | 3.28B | 2.9B | 2.53B | 2.49B | 2.37B |
Research & Development | 640.01M | 634M | 604M | 530M | 473M | 485M |
Other Expenses | n/a | 1.38B | 1.74B | 2.25B | 2.63B | 2.25B |
Operating Expenses | 4.14B | 5.3B | 5.24B | 5.31B | 5.59B | 5.1B |
Interest Expense | 1.64B | 1.39B | 1.33B | 1.46B | 1.43B | 1.53B |
Selling & Marketing Expenses | n/a | 786M | 625M | 518M | 515M | 451M |
Cost & Expenses | 8.22B | 8.08B | 7.79B | 7.67B | 7.98B | 7.35B |
Income Tax Expense | 251.32M | 239M | 221M | 83M | -87M | -375M |
Shares Outstanding (Basic) | 370.9M | 368M | 365.43M | 362M | 358.9M | 355M |
Shares Outstanding (Diluted) | 375M | 368M | 364.9M | 362M | 358.9M | 355M |
EPS (Basic) | 0.43 | -0.13 | -1.62 | -0.62 | -2.61 | -1.57 |
EPS (Diluted) | 0.43 | -0.13 | -1.62 | -0.62 | -2.61 | -1.57 |
EBITDA | 3.24B | 3.13B | 2.89B | 2.88B | 3.26B | 3.14B |
EBIT | 2.02B | 1.87B | 1.62B | 1.48B | 1.71B | 1.31B |
Depreciation & Amortization | 1.23B | 1.27B | 1.26B | 1.39B | 1.55B | 1.83B |
Add to Watchlist
Select watchlists to add or remove BHC